PD

Marco

Wachtel, PhD

2018: Habilitation at the medical faculty of the University of Zurich entitled «Biology of fusion proteins in sarcoma»
1997-2001: PhD thesis at the Swiss Federal Institute of Technology (ETH) Zurich entitled «Influence of tyrosine phosphorylation and ischemia on paracellular permeability in endothelia cells»
1992-1997: Studies of biology (specialization XAe) at the Swiss Federal Institute of Technology (ETH) Zurich 

2013: Posterprice FZK Retreat University Children`s Hospital Zurich
2004-2005: Forschungskredit Postdoc from University Zurich
2004: Nestlè Young Research Award at Research Day of Swiss Society of Pediatrics

• Scientific Reviewer for the following journals/foundations
  • HISTOLOGY AND HISTOPATHOLOGY
  • The Alan B.Slifka Foundation 
  • International Journal of Molecular Sciences

• since 2011: American Association for Cancer Research (AACR)

• Biology of fusion oncogenes in sarcoma. Special focus on PAX3-FOXO1, the main driver of alveolar rhabdomyosarcoma.
• Drug response profiling of sarcoma using patient-derived ex-vivo models.

• 2021-2023: OncoSuisse Research Grant (Co-Applicant)
• 2012-2014: OncoSuisse Research Grant (Co-Applicant)
• 2004-2005: Forschungskredit Postdoc from University Zurich

• ORCID